The Allegra transcatheter heart valve: Long-term clinical and echocardiographic outcomes
CONCLUSIONS: Transfemoral implantation of the Allegra-THV resulted in favorable clinical and echocardiographic outcomes at up to 3-year follow-up. Head-to-head randomized clinical trials are necessary to determine if the Allegra-THV valve performs as well as current generation valves.PMID:38108869 | DOI:10.25270/jic/23.00163
Source: The Journal of Invasive Cardiology - Category: Cardiology Authors: Mathias Wolfrum Federico Moccetti Nina Conrad Lucca Loretz Matthias Bossard Adrian Attiger-Toller Florim Cuculi Stefan Toggweiler Source Type: research
More News: Academia | Alfalfa | Allegra | Antibiotic Therapy | Cardiology | Cardiovascular | Clinical Trials | Endocarditis | France Health | Heart | Heart Valve Disease | Heart Valve Surgery | Heart Valves | Thrombosis | Women